Analysis of platelet indice (MPV, PDW) on the severity of COVID-19 patients
Abstract
The COVID-19 virus infection some time ago caused a pandemic and became a health problem in the world, including Indonesia. The cause of COVID-19 infection is the SARS-CoV-2 virus which can be detected by Real Time reverse-transcriptase polymerase chain reaction (rRT-PCR). Platelets play a role in inflammation and the pathogenesis of various inflammatory clinical conditions which are also affected by COVID-19 infection, which can change according to the severity of the infection. The purpose of this study was to analyze differences in MPV and PDW in the severity of COVID-19 patients. This type of research is an analytic observational study with a cross sectional research design. Data on platelet index values and the degree of severity were obtained from medical records during the period June to August 2021 from 209 COVID-19 patients treated at RSUD Dr. H. Abdul Moeloek Lampung Province. Statistical tests were carried out using the Kruskal Wallis Annova test, followed by the Mann Whitney test. The results showed that there was a significant difference in the PDW index (p = 0.004) to the degree of severity of COVID-19, while the MPV index was not significantly different to the degree of severity of COVID-19. Excessive production of cytokines and acute phase reactants due to immune response and inflammation for COVID-19 infection, thereby affecting the development of megakaryocytes resulting in changes in the PDW Platelet index, the pathogenesis of SARS-CoV-2 infection is very complex and it is possible that the early stages of the disease do not affect all parameters hematology.
Copyright (c) 2023 Sofwan Halimi, Endah Setyaningrum, Sutyarso Sutyarso, Nuning Nurcahyani, Hidayat Hidayat
This work is licensed under a Creative Commons Attribution 4.0 International License.
COPYRIGHT AND LICENSE STATEMENT
COPYRIGHT
Biogenesis: Jurnal Ilmiah Biologi is published under the terms of the Creative Commons Attribution license. Authors hold the copyright and retain publishing rights without restriction to their work. Users may read, download, copy, distribute, and print the work in any medium, provided the original work is properly cited.
LICENSE TO PUBLISH
1. License
The use of the article will be governed by the Creative Commons Attribution license as currently displayed on http://creativecommons.org/licenses/by/4.0.
2. Author’s Warranties
The author warrants that the article is original, written by stated author/s, has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
3. User Rights
Under the Creative Commons Attribution license, the users are free to download, reuse, reprint, modify, distribute and/or copy the content for any purpose, even commercially, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
4. Co-Authorship
If the article was prepared jointly with other authors, the corresponding author warrants that he/she has been authorized by all co-authors, and agrees to inform his/her co-authors of the terms of this statement.
5. Miscellaneous
Biogenesis: Jurnal Ilmiah Biologi may conform the article to a style of punctuation, spelling, capitalization, and usage that it deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers.
